Complete Omics Inc. is a leader in clinical grade proteomics tests, and we are the inventor of mutant protein quantification technology and neoantigen detection and quantification technology through mass spectrometry-based proteomics assays. Our genomics service is backed by the world’s first dual RNA probe-based DNA duplex capture method to achieve ultra-rare mutation calling from very tough samples, such as degraded DNA or fossil samples.